#USA #Cincinnati #Cincinnati Children's #respiratory testing #pediatric hospitals

Understanding the Rising Costs of Respiratory Testing in Pediatric Care

A recent study published in JAMA Network Open has unveiled a concerning trend in the pediatric healthcare sector: a significant increase in the cost and frequency of respiratory testing for children. Conducted by Cincinnati Children's Hospital and several other institutions, this research sheds light on shifts in testing practices that have emerged in the wake of the COVID-19 pandemic.

Expanding Test Practices

The increase in respiratory testing practices can be traced back to early in the pandemic when traditional methods were disrupted. As the world grappled with COVID-19, many hospitals, including pediatric facilities, started to adopt more complex and expensive testing panels when children presented with respiratory issues. These large-panel tests search for multiple infectious agents, leading to a higher overall testing cost.

According to the study, between 2017 and 2022, the cost for respiratory testing per hospital visit escalated drastically, from an average of $34.20 to $128.20. These escalating costs reflect not only an increase in the number of tests ordered but also a shift in the types of tests being utilized. The prevalence of large-panel tests that can assess for more than five conditions has significantly surged, contributing to unnecessary financial burdens on healthcare systems.

Alarming Statistics

The statistics presented in the study are striking. Tests were ordered for 13.6% of children with respiratory issues in 2016, a figure that ballooned to 62.2% by 2022. The shift emphasizes a national trend towards more aggressive and expensive testing protocols, which may not significantly alter treatment outcomes. This comprehensive data was derived from over 5 million patient encounters recorded in the Pediatric Health Information System, providing a substantial basis for the study's conclusions.

This increase has raised alarms among healthcare professionals, as parents and caregivers may be burdened with unexpected medical expenses driven by unwanted or excessive testing. Notably, there has been little evidence suggesting that increased testing leads to enhanced clinical outcomes or a decrease in antibiotic prescriptions, especially when testing for viral infections where antibiotics are ineffective.

The Importance of Deimplementation

Experts advocate for a more focused and judicious approach to testing, an initiative referred to as deimplementation. Matthew Molloy, MD, MPH, a lead researcher in the study, emphasizes the necessity of reassessing testing protocols to ensure that healthcare resources are effectively allocated to provide the highest value of care.

Understanding the causes of these cost increases is essential in reshaping testing guidelines. Incrementally, clinicians are encouraged to return to a more evidence-based rationale for ordering tests, favoring single-virus testing when appropriate over more elaborate options.

The broad impact of these findings can shape future health policies and clinical practices, aiming to ensure both cost-effectiveness and quality of care. The medical community has been called to action to evaluate their testing habits critically during this transitional time.

Conclusion

As healthcare continues to adapt to lessons learned during the pandemic, this study propels a conversation about responsible testing in pediatric medicine. With rising costs affecting both families and the healthcare system, addressing these issues can facilitate a more sustainable approach to managing respiratory infections in children. The findings underscore the need for careful consideration and reform in pediatric testing practices, aligning them with clinical needs rather than trends driven by external factors.

This comprehensive study serves as a critical reminder for healthcare professionals and policymakers to prioritize patient care effectively while managing costs in a post-COVID healthcare environment.